Search results for

Several other countries including France, Germany, the Netherlands and Ireland moved to suspend injections of the vaccine this week.

The Central Ohio Transit Authority is launching two free initiatives to help underserved communities get to COVID-19 vaccination sites.The Ohio Department…

Many people think of Antarctica as desolate. But wildlife filmmaker Ariel Waldman says the coldest continent is brimming with invisible life — that can only be seen through microscopes.

On Cincinnati Edition 's weekly news review:

President Joe Biden visited with officials at Ohio State's James Comprehensive Cancer Center in Columbus on Tuesday, where he talked about the expansion…

Many psychedelic drugs are illegal in the U.S. But Rick Doblin says psychedelic-assisted therapy helps many patients get to the core of their trauma.

Gov. Mike DeWine says a new health order will mandate nursing homes and assisted living facilities allow visits when there is not a COVID…

Reynoldsburg City Schools began its second week with an altered bus schedule and some of its students learning from home due to fewer available bus drivers.

In the field of bio-tech, it can take 10 years and millions of dollars to see if an experimental idea might turn into a life-saving treatment—if it ever does. Noubar Afeyan fully understood those risks when he co-founded Moderna in 2010. He and his colleagues were looking for a way to deploy the messenger RNA molecule to tackle life-threatening diseases. In January of 2020, an urgent opportunity presented itself in the form of a deadly virus that was spreading across the globe. At a breathtaking pace, Moderna produced a prototype for a COVID-19 vaccine, partnered with the NIH to test it, and produced millions of doses, becoming part of the most rapid vaccine roll-out in human history. While Moderna is the best known of Noubar's companies, he has launched many others in the bio-tech space as part of Flagship Pioneering, his multi-billion dollar venture studio.

The man who has spoken for President Bush for nearly three years is leaving the pressroom podium, as Scott McClellan announces his resignation as White House press secretary. In another shift, President Bush's key strategic advisor, Karl Rove, will shed one of his administration jobs.